Results 111 to 120 of about 72,539 (214)

Hispania romana

, 2007
ESP
openaire   +1 more source

Cardiorenal benefits of finerenone: protecting kidney and heart. [PDF]

Ann Med, 2023
González-Juanatey JR, Górriz JL, Ortiz A, Valle A, Soler MJ, Facila L.   +5 more
europepmc   +1 more source

La Política Municipal de los Flavios en Hispània. El Municipium Irnitanum

Studia Historica: Historia Antigua, 2009
La Hispània del 68 d. C. sólo haba sufrido superficialmente los efectos del caos en que los últimos años de Nerón habían sumido al gobierno de Roma. Los excesos cometidos en la ciudad por el último de los Julio-Claudios, en materia de gasto y despilfarro
Joaquín MUÑIZ COELLO
doaj  

Correction: Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies. [PDF]

Trials
Schaefer F, Montini G, Kang HG, Walle JV, Zaritsky J, Schreuder MF, Litwin M, Scalise A, Scott H, Potts J, Iveli P, Breitenstein S, Warady BA.   +12 more
europepmc   +1 more source

Usefulness of the Heavy Menstrual Bleeding Diagnostic Tools SAMANTA Questionnaire and Heavy Menstrual Bleeding-Visual Analog Scale Tool for Iron Deficiency Screening: An Exploratory Analysis from the COLIBRI Study. [PDF]

Womens Health Rep (New Rochelle)
Perelló-Capó J, Estadella-Tarriel J, Gich-Saladich I, Llurba-Olivé E, Calaf-Alsina J.   +4 more
europepmc   +1 more source

Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome. [PDF]

Res Pract Thromb Haemost
Marco-Rico A, Fernández-Bello I, Mateo-Sotos J, Marco-Vera P.   +3 more
europepmc   +1 more source

Heavy Menstrual Bleeding-Visual Analog Scale, an Easy-to-Use Tool for Excessive Menstrual Blood Loss That Interferes with Quality-of-Life Screening in Clinical Practice. [PDF]

Womens Health Rep (New Rochelle), 2022
Perelló J, Pujol P, Pérez M, Artés M, Calaf J.   +4 more
europepmc   +1 more source

Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studies. [PDF]

Front Cardiovasc Med
Escobar C, Caravaca-Pérez P, Fernandez Rodriguez JM, Gomez-Otero I, Lozano-Bahamonde A, Pérez-Cabeza AI, Pérez-Silvestre J, Rafols C, Esteban-Fernández A.   +8 more
europepmc   +1 more source

Qualitative Evaluation of a Clinical Decision-Support Tool for Improving Anticoagulation Control in Non-Valvular Atrial Fibrillation in Primary Care. [PDF]

Healthcare (Basel)
Dalmau Llorca MR, Castro Blanco E, Hernández Rojas Z, Carrasco-Querol N, Medina-Perucha L, Gonçalves AQ, Espuny Cid A, Fernández Sáez J, Aguilar Martín C.   +8 more
europepmc   +1 more source

Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study. [PDF]

Cardiol J, 2022
Anguita Sánchez M, Marín F, Masjuan J, Cosín-Sales J, Vázquez Rodríguez JM, Barrios V, Barón-Esquivias G, Lekuona I, Pérez-Cabeza AI, Freixa-Pamias R, Parra Jimenez FJ, Monzer Khanji Khatib M, Rafols Priu C, Sanmartín Fernández M.   +13 more
europepmc   +1 more source